What does peptide mapping add for semaglutide that a purity figure does not?

The specifics, since they change the answer: peptide mapping · semaglutide.

The comparison I want does not seem to exist anywhere in a form I can evaluate.

I have read the arguments for each and they do not engage with each other.

Which axes does this decision turn on?

Concretely, reading a content result requires knowing the purity of the standard against which the sample was quantified, because your result inherits that uncertainty.

For peptides at 214 nanometres the response is roughly proportional to the number of peptide bonds, so truncation impurities have lower response factors and overestimate content.

Reconciling gross mass to label claim

System suitability for a quantitative method is stricter than for purity because a small systematic error in the standard directly translates into an error in the sample result.

Quantitation against a standard requires that the standard be traceable to a national metrology institute, and certificates for research-grade standards claim that traceability.

If a supplier gives you content without the standard's purity, ask them to provide it.

The short answer is that purity says "what fraction of detected material is the target" while content says "how many milligrams of the target are present," and those are two different things.

The single most common reason for disagreement between a supplier content figure and an independent assay is using different standards.

Put another way, if a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.

Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.

Ask for both the purity and the content, and do not accept purity alone.

Start from what you are trying to know — whether a vial contains what the label claims — and purity does not answer that question.

Water content and counter-ion content are part of the gross mass but not part of the content assay result, which is why the two do not sum to label claim.

Stated carefully, the purity of the reference standard is stated on its certificate, and your content figure is only as good as that purity certificate is.

Where content data have been published from testing services on common peptides, the spread between services on identical material is typically a few per cent.

Worth noting that the standard certificate carries its own uncertainty, usually on the order of two to three per cent, which the sample result inherits.

The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.

Content assay requires a reference standard of known purity and traceability, which is why it costs more than purity testing does.

Peak area for a standard of known weight produces a response factor — area per unit mass — which is then applied to the sample peak to infer sample mass.

The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.

I would not rely on a content figure from a lab that is not willing to state their standard's purity on request.

If a supplier gives you content without the standard's purity, ask them to provide it.

A high purity does not guarantee high content because it says nothing about how much of anything is in the vial — a vial could be 99 per cent pure but only half full.

Running multiple independent aliquots of the same sample should give results that agree to within the method precision, which is usually one to three per cent.

The caveat is that content assay costs more than purity, so most people do not do it, which is exactly why it is valuable on the first lot from a new supplier.

Ask for both the purity and the content, and do not accept purity alone.